LuxExperience's Turnaround Is Real-But $7.50 Still Prices Too Much Hope

Profitability is credible, but the stock still prices in too much hope

At $7.50, LuxExperience has earned credit for turning the turnaround into reported a second consecutive quarter of adjusted EBITDA profitability at a 0.9% margin. But profitability is the starting line for valuation, not proof the stock is cheap.

That helps explain the split reaction. Bulls see evidence that management's cost reset is sticking and could support a richer multiple later. Bears see a different problem: the group's top line was only stable +0.0% on a constant currency basis. In other words, investors are being asked to pay for future operating leverage before there is much revenue momentum behind it.

That is the real tension. After a painful restructuring, some investors treat any move to profit as a reason to re-rate the name. I think that is too easy. The improvement is real, but it is still early. A 0.9% adjusted EBITDA margin leaves little room for disappointment if the next quarter's sales stay flat.

That optimism is already showing up in Street targets. The published range is $8.00 to $12.00, with a $9.50 average. That means a meaningful part of the upside case is already in consensus. The company's 7–9% medium-term margin target matters, but it is also the anchoring risk: if investors fixate on that goal too early, they can overpay for progress that still needs to scale.

Mytheresa shows the portfolio has quality, but not yet a full recovery

Mytheresa is the clearest proof that this portfolio is not starting from zero. In Q3, it delivered +9.9% net sales growth on a constant currency basis with a 5.5% adjusted EBITDA margin. That followed +12.7% GMV growth ex-FX and a 9.3% adjusted EBITDA margin in Q2. The earlier full-year read also matters: Mytheresa finished FY25 with +8.9% net sales growth. That is the best quality signal in the report: a premium platform is still growing through headwinds, not just surviving through cost cuts.

Why Mytheresa can become an anchoring trap

That is also where the narrative risk begins. One strong platform can create a false sense of breadth. Investors see Mytheresa's profitability and growth, then implicitly assume the rest of the group is close to the same inflection. That fits the turnaround story nicely, but it is not the same as evidence.

The group does show real operating repair. Management said it saw significant improvements on many KPIs across all three business segments, and the cost base improved as the Group Adjusted SG&A cost ratio fell to 18.3% in Q3 FY26. Even so, the recovery still looks uneven rather than broad-based. Mytheresa is growing, but the rest of the group still has further to go.

That is why the market may be reading too much into the latest quarter. Cost discipline is real. Execution has improved. But portfolio-wide recovery is not there yet. Mytheresa proves there is a strong engine inside the group; it does not prove the whole group is running evenly.

Why I'm still waiting for more proof

That is why I remain on the sidelines: at $7.51 current price, LuxExperience is no longer a pure turnaround bet. It is a "prove the repair can scale" trade.

What would make LUXE buyable

A Hold stance is not indecision. It means the company has cleared the first hurdle, but the stock is no longer priced like a cheap option. The Street already carries an $8.00 to $12.00 target range and a $9.50 average target. The next step has to come from the business, not just from rerating expectations.

I would get more interested if:

• The next quarter shows that profitability was not only a cost-control outcome, but the start of operating leverage tied to demand.
• The group moves from stabilization toward genuine growth, not just from loss-making to break-even.
• The market starts reflecting a cleaner growth profile, not only a cleaner income statement.

Those are the signals that would justify paying for a richer multiple. Until then, $7.50 is still too expensive for me.